IIPLA Newsroom

IIPLA News

Daily reporting, analysis, and legal-market coverage across patents, trademarks, copyright, licensing, disputes, and policy.

News Archive

Latest IP news

Filtered news

News results

3 articles matching your filters, newest first.

Korea and Japan Launch Continuous Intellectual Property Policy Cooperation After 45 Years
Patentskorea

Korea and Japan Launch Continuous Intellectual Property Policy Cooperation After 45 Years

Korea Patent Attorneys Association and Japan’s Lawyers Society form working group to enhance bilateral IP systems and competitiveness

Marking a historic shift since 1981, Korea and Japan transition from annual intellectual property exchanges to a continuous policy cooperation framework. The Korea Patent Attorneys Association and Japan’s Lawyers Society have established a joint working group to address critical IP issues including finance, disclosure…

Wednesday, September 16, 2026
IIPLA News Desk
Tokyo Court Imposes Prison Sentence and Fine for Spoiler-Filled Copyright Infringement
CopyrightGlobal

Tokyo Court Imposes Prison Sentence and Fine for Spoiler-Filled Copyright Infringement

Godzilla and Overlord Rights Holders Secure Criminal Conviction Against Website Owner for Detailed Plot Summaries

A Tokyo District Court has sentenced a website owner to 18 months in prison and imposed a fine exceeding $6,000 for publishing spoiler-heavy posts containing extensive plot details and images from the films Godzilla Minus One and the anime series Overlord. The conviction, initiated by complaints from major Japanese co…

Thursday, April 30, 2026
IIPLA News Desk
Genprex Secures Key Japanese and European Patents for REQORSA Gene Therapy Combined with Immunotherapies in Cancer Treatment
PatentsGlobal

Genprex Secures Key Japanese and European Patents for REQORSA Gene Therapy Combined with Immunotherapies in Cancer Treatment

Patents bolster Genprex’s global IP portfolio, supporting ongoing Acclaim-3 clinical trial for small cell lung cancer with PD-L1 and PD-1 antibody combinations

Genprex, Inc. has obtained favorable patent grants from the Japanese Patent Office and European Patent Office covering the use of its REQORSA gene therapy in combination with PD-L1 and PD-1 antibodies to treat cancer. These patents reinforce Genprex’s intellectual property rights in major markets and underpin its Accl…

Monday, February 23, 2026
IIPLA News Desk
Page 1 of 1
Newsroom tools
Newsletters & Digests

Subscribe to IIPLA Newsroom

Get Top 5 IP News Today, weekly editorial roundups, and region-aware updates tailored to your practice.

Choose your regions
Choose your categories
By subscribing, you agree to receive IIPLA newsroom emails. You can update preferences or unsubscribe anytime.